BiomX
Biotech solutions company
BiomX has raised €50M across 2 funding rounds from 7 investors, most recently a Series B round in Jan 2019. Based in Ness Ziona, Israel; active in Fintech and Healthtech. Data as of 4 Nov 2026.
Ness Ziona, Israelbiomx.com ↗
Total raised
€50M
€49,821,459
Funding rounds
2
Investors
7
distinct backers
Active since
2017-05
latest 2019-01
Funding by year
EUR raised per yearBiomX — funding by year — interactive chart.
Data table
| BiomX — funding by year | |
|---|---|
| 2017 | €22M |
| 2018 | €28M |
Signals
High confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series B | €28M | RM Global Partners,Seventure Partners | View deal → |
| 2017-05-16 | Series A | €22M | Innovation SBI Japan-Israel Innovation Fund,Johnson & Johnson,Mirae Asset Venture Investment,OrbiMed,Seventure Partners,Takeda Ventures | View deal → |